Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels

S. Okamura, T. Osaki, K. Nishimura, H. Ohsaki, M. Shintani, H. Matsuoka, K. Maeda, Kazuya Shiogama, T. Itoh, S. Kamoshida

Research output: Contribution to journalArticle

Abstract

Although angiogenesis plays a crucial role in cancer growth and progression, no reliable method for assessing angiogenesis in tumor tissue sections currently is available. Using biomarkers with high specificity for proliferating endothelial cells could help quantify angiogenic activity. Thymidine kinase-1 (TK1) is an enzyme involved in the salvage pathway of DNA synthesis and its activity is correlated with cell proliferation. We investigated the use of double immunostaining for TK1 and CD31 for identifying activated tumor vessels. Differences in TK1/CD31 positive vessel rates (PVRs) between tumor and adjacent normal tissues were evaluated in 39 colorectal carcinoma (CRC) samples and compared with those of Ki67/CD31 double stained tissues. Mean TK1/CD31 PVR (23.6%) in CRCs was 13.9 fold greater than in adjacent normal tissues (1.7%)). By comparison, mean Ki67/CD31 PVR in CRCs was 20.0%, i.e. only 4.8 fold greater than in normal tissues (4.2%). Also, mean TK1/CD31 PVR in normal tissues was significantly less than mean Ki67/CD31 PVR. Our findings indicate that double immunostaining for TK1/CD31 can detect activated tumor vessels more accurately than staining for Ki67/CD31 and potentially could identify tumors that will respond to anti-angiogenic therapy.

Original languageEnglish
Pages (from-to)60-64
Number of pages5
JournalBiotechnic and Histochemistry
Volume94
Issue number1
DOIs
Publication statusPublished - 02-01-2019

Fingerprint

Neoplasms
thymidine kinase 1
Colorectal Neoplasms
Endothelial Cells
Biomarkers
Cell Proliferation
Staining and Labeling
DNA
Enzymes
Growth
Therapeutics

All Science Journal Classification (ASJC) codes

  • Histology
  • Medical Laboratory Technology

Cite this

Okamura, S., Osaki, T., Nishimura, K., Ohsaki, H., Shintani, M., Matsuoka, H., ... Kamoshida, S. (2019). Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels. Biotechnic and Histochemistry, 94(1), 60-64. https://doi.org/10.1080/10520295.2018.1499962
Okamura, S. ; Osaki, T. ; Nishimura, K. ; Ohsaki, H. ; Shintani, M. ; Matsuoka, H. ; Maeda, K. ; Shiogama, Kazuya ; Itoh, T. ; Kamoshida, S. / Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels. In: Biotechnic and Histochemistry. 2019 ; Vol. 94, No. 1. pp. 60-64.
@article{edc26ccd3ff8495bbed7d05dbdab09c1,
title = "Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels",
abstract = "Although angiogenesis plays a crucial role in cancer growth and progression, no reliable method for assessing angiogenesis in tumor tissue sections currently is available. Using biomarkers with high specificity for proliferating endothelial cells could help quantify angiogenic activity. Thymidine kinase-1 (TK1) is an enzyme involved in the salvage pathway of DNA synthesis and its activity is correlated with cell proliferation. We investigated the use of double immunostaining for TK1 and CD31 for identifying activated tumor vessels. Differences in TK1/CD31 positive vessel rates (PVRs) between tumor and adjacent normal tissues were evaluated in 39 colorectal carcinoma (CRC) samples and compared with those of Ki67/CD31 double stained tissues. Mean TK1/CD31 PVR (23.6{\%}) in CRCs was 13.9 fold greater than in adjacent normal tissues (1.7{\%})). By comparison, mean Ki67/CD31 PVR in CRCs was 20.0{\%}, i.e. only 4.8 fold greater than in normal tissues (4.2{\%}). Also, mean TK1/CD31 PVR in normal tissues was significantly less than mean Ki67/CD31 PVR. Our findings indicate that double immunostaining for TK1/CD31 can detect activated tumor vessels more accurately than staining for Ki67/CD31 and potentially could identify tumors that will respond to anti-angiogenic therapy.",
author = "S. Okamura and T. Osaki and K. Nishimura and H. Ohsaki and M. Shintani and H. Matsuoka and K. Maeda and Kazuya Shiogama and T. Itoh and S. Kamoshida",
year = "2019",
month = "1",
day = "2",
doi = "10.1080/10520295.2018.1499962",
language = "English",
volume = "94",
pages = "60--64",
journal = "Biotechnic and Histochemistry",
issn = "1052-0295",
publisher = "Informa Healthcare",
number = "1",

}

Okamura, S, Osaki, T, Nishimura, K, Ohsaki, H, Shintani, M, Matsuoka, H, Maeda, K, Shiogama, K, Itoh, T & Kamoshida, S 2019, 'Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels', Biotechnic and Histochemistry, vol. 94, no. 1, pp. 60-64. https://doi.org/10.1080/10520295.2018.1499962

Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels. / Okamura, S.; Osaki, T.; Nishimura, K.; Ohsaki, H.; Shintani, M.; Matsuoka, H.; Maeda, K.; Shiogama, Kazuya; Itoh, T.; Kamoshida, S.

In: Biotechnic and Histochemistry, Vol. 94, No. 1, 02.01.2019, p. 60-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels

AU - Okamura, S.

AU - Osaki, T.

AU - Nishimura, K.

AU - Ohsaki, H.

AU - Shintani, M.

AU - Matsuoka, H.

AU - Maeda, K.

AU - Shiogama, Kazuya

AU - Itoh, T.

AU - Kamoshida, S.

PY - 2019/1/2

Y1 - 2019/1/2

N2 - Although angiogenesis plays a crucial role in cancer growth and progression, no reliable method for assessing angiogenesis in tumor tissue sections currently is available. Using biomarkers with high specificity for proliferating endothelial cells could help quantify angiogenic activity. Thymidine kinase-1 (TK1) is an enzyme involved in the salvage pathway of DNA synthesis and its activity is correlated with cell proliferation. We investigated the use of double immunostaining for TK1 and CD31 for identifying activated tumor vessels. Differences in TK1/CD31 positive vessel rates (PVRs) between tumor and adjacent normal tissues were evaluated in 39 colorectal carcinoma (CRC) samples and compared with those of Ki67/CD31 double stained tissues. Mean TK1/CD31 PVR (23.6%) in CRCs was 13.9 fold greater than in adjacent normal tissues (1.7%)). By comparison, mean Ki67/CD31 PVR in CRCs was 20.0%, i.e. only 4.8 fold greater than in normal tissues (4.2%). Also, mean TK1/CD31 PVR in normal tissues was significantly less than mean Ki67/CD31 PVR. Our findings indicate that double immunostaining for TK1/CD31 can detect activated tumor vessels more accurately than staining for Ki67/CD31 and potentially could identify tumors that will respond to anti-angiogenic therapy.

AB - Although angiogenesis plays a crucial role in cancer growth and progression, no reliable method for assessing angiogenesis in tumor tissue sections currently is available. Using biomarkers with high specificity for proliferating endothelial cells could help quantify angiogenic activity. Thymidine kinase-1 (TK1) is an enzyme involved in the salvage pathway of DNA synthesis and its activity is correlated with cell proliferation. We investigated the use of double immunostaining for TK1 and CD31 for identifying activated tumor vessels. Differences in TK1/CD31 positive vessel rates (PVRs) between tumor and adjacent normal tissues were evaluated in 39 colorectal carcinoma (CRC) samples and compared with those of Ki67/CD31 double stained tissues. Mean TK1/CD31 PVR (23.6%) in CRCs was 13.9 fold greater than in adjacent normal tissues (1.7%)). By comparison, mean Ki67/CD31 PVR in CRCs was 20.0%, i.e. only 4.8 fold greater than in normal tissues (4.2%). Also, mean TK1/CD31 PVR in normal tissues was significantly less than mean Ki67/CD31 PVR. Our findings indicate that double immunostaining for TK1/CD31 can detect activated tumor vessels more accurately than staining for Ki67/CD31 and potentially could identify tumors that will respond to anti-angiogenic therapy.

UR - http://www.scopus.com/inward/record.url?scp=85055053347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055053347&partnerID=8YFLogxK

U2 - 10.1080/10520295.2018.1499962

DO - 10.1080/10520295.2018.1499962

M3 - Article

VL - 94

SP - 60

EP - 64

JO - Biotechnic and Histochemistry

JF - Biotechnic and Histochemistry

SN - 1052-0295

IS - 1

ER -